What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Antibody
His primary areas of investigation include Immunology, Antigen, Molecular biology, Lewis lung carcinoma and In vitro.
His study in Immunology is interdisciplinary in nature, drawing from both Cytotoxic T cell, Transfection and Virology.
He has included themes like Cell culture, Peptide and B cell in his Antigen study.
His research in Molecular biology intersects with topics in Antibody, Gene and Transplantation.
His Lewis lung carcinoma study combines topics in areas such as Lung and Major histocompatibility complex.
His studies examine the connections between In vitro and genetics, as well as such issues in Cell biology, with regards to Tissue culture.
His most cited work include:
- Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. (440 citations)
- Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection (356 citations)
- HTLV-III in cells cultured from semen of two patients with AIDS (283 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Antigen, Molecular biology, In vitro and Cancer research.
His Immunology research is multidisciplinary, relying on both Cytotoxic T cell and Transplantation.
The study incorporates disciplines such as Cell, Antibody and Cell biology in addition to Antigen.
His Molecular biology research also works with subjects such as
- Cytolysis most often made with reference to Lymphocyte,
- Receptor, which have a strong connection to Tuftsin.
His Cancer research research incorporates themes from Lewis lung carcinoma, Gene, In vivo and Pathology.
Michael Feldman has researched Immune system in several fields, including Virus and Virology.
He most often published in these fields:
- Immunology (42.98%)
- Antigen (38.43%)
- Molecular biology (30.17%)
What were the highlights of his more recent work (between 1990-2008)?
- Immunology (42.98%)
- Cancer research (21.07%)
- CTL* (5.37%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, Cancer research, CTL*, Antigen and Immunotherapy.
His Immunology study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Transfection.
Michael Feldman interconnects Pathology, Lewis lung carcinoma, Metastasis, Gene and In vivo in the investigation of issues within Cancer research.
In his research on the topic of CTL*, Cellular immunity and Beta-2 microglobulin is strongly related with Peptide.
His research on Antigen frequently connects to adjacent areas such as Carcinoma.
His work deals with themes such as Interferon and Virology, which intersect with Immune system.
Between 1990 and 2008, his most popular works were:
- Interleukin 6 Gene Transfection into Lewis Lung Carcinoma Tumor Cells Suppresses the Malignant Phenotype and Confers Immunotherapeutic Competence against Parental Metastatic Cells (241 citations)
- CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma (231 citations)
- C-C Chemokines, Pivotal in Protection Against HIV Type 1 Infection (196 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
Michael Feldman mainly focuses on Immunology, Immunotherapy, CTL*, MHC class I and Cytokine.
His specific area of interest is Immunology, where Michael Feldman studies Antigen.
His biological study spans a wide range of topics, including CD8 and Transfection.
As part of one scientific family, Michael Feldman deals mainly with the area of Lewis lung carcinoma, narrowing it down to issues related to the Clone, and often Cancer research.
His research integrates issues of Molecular biology and Vaccination in his study of Peptide.
His Cytotoxic T cell research integrates issues from Epitope and Immune system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
